Skip to main content

Table 3 Dosimetric outcomes

From: The MRI-guided two adaptive brachytherapy fractions versus one adaptive brachytherapy fraction in one application for the cervical cancer: a retrospective study

Parameters

Arm 1 (n = 63)

Arm 2 (n = 57)

P value

Median (IQR)

Median (IQR)

HR-CTV D90, Gy

90.6 (88.25–92.21)

91.40 (86.89–93.61)

0.398

Initial HR-CTV, cm3

34.23 (25.78–58.80)

49.85 (37.66–75.18)

0.003

Bladder D2cc, Gy

77.44 (72.37–80.01)

82.05 (78.88–84.63)

 < 0.001

Rectum D2cc, Gy

65.84 (61.14–69.59)

65.01 (60.63–69.94)

0.889

Sigmoid D2cc, Gy

65.72 (58.77–69.44)

67.28 (63.71–71.45)

0.022

Small bowel D2cc, Gy

64.14 (60.10–68.06)

67.64 (63.0–69.47)

0.005

  1. IQR Inter Quartile Range
  2. Bold values indicate statistically significance